Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.38 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.38 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.38 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.38 |
| ▸ | CDC7 | O00311 | 2/20 | 0.37 |
| ▸ | PIM1 | P11309 | 2/20 | 0.37 |
| ▸ | CSNK2B | P67870 | 2/20 | 0.37 |
| ▸ | CSNK2A1 | P68400 | 2/20 | 0.37 |
| ▸ | PARP1 | P09874 | 2/20 | 0.36 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.35 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.35 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL903360 | 1.00 | SCN10A (0.38) | SCN10ACHRNB2CHRNA7CHRNA4CDC7 | |
| Hydrochloric Acid SCHEMBL1591999 | 0.98 | SCN10A (0.37) | SCN10ACHRNB2CHRNA7CHRNA4CDC7 | |
| SCHEMBL955468 | 0.79 | CHRM2 (0.41) | SCN10ACHRNB2CHRNA7CHRNA4CDC7 | |
| SCHEMBL1813465 | 0.79 | SCN10A (0.38) | SCN10ACHRNB2CHRNA7CHRNA4PARP1 | |
| SCHEMBL1813463 | 0.79 | SCN10A (0.38) | SCN10ACHRNB2CHRNA7CHRNA4PARP1 | |
| SCHEMBL955469 | 0.79 | CHRM2 (0.41) | SCN10ACHRNB2CHRNA7CHRNA4CDC7 | |
| Hydrochloric Acid SCHEMBL12098711 | 0.77 | SCN10A (0.37) | SCN10ACHRNB2CHRNA7CHRNA4PARP1 | |
| Hydrochloric Acid SCHEMBL12098713 | 0.77 | SCN10A (0.37) | SCN10ACHRNB2CHRNA7CHRNA4PARP1 | |
| SCHEMBL2683531 | 0.77 | CDC7 (0.40) | SCN10ACHRNB2CHRNA7CHRNA4CDC7 | |
| SCHEMBL1981541 | 0.77 | CDC7 (0.40) | SCN10ACHRNB2CHRNA7CHRNA4CDC7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-106008552-B | Benzo [ e ] pyrazolo [1,5-c ] [1,3] oxazine compound and application thereof | 南京圣和药业股份有限公司 | 2020-08-21 | — | — | CN | disclosed |
| CN-105985355-B | Fused tricyclic hepatitis virus inhibitor and application thereof | 南京圣和药业股份有限公司 | 2020-05-05 | — | — | CN | disclosed |
| US-9512108-B2 | 9,9,10,10-Tetrafluoro-9,10-dihydrophenanthrene hepatitis C virus inhibitor and application thereof | NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) | 2016-12-06 | — | — | US | disclosed |
| EP-3091010-A1 | 9,9,10,10-TETRAFLUORO-9,10-DIHYDROPHENANTHRENE HEPATITIS C VIRUS INHIBITOR AND APPLICATION THEREOF | Nanjing Sanhome Pharmaceutical Co., Ltd. (CN) | 2016-11-09 | — | — | EP | disclosed |
| US-20160297804-A1 | 9,9,10,10-TETRAFLUORO-9,10-DIHYDROPHENANTHRENE HEPATITIS C VIRUS INHIBITOR AND APPLICATION THEREOF | NANJING SANHOME PHARMACEUTICAL CO., LTD. (CN) | 2016-10-13 | — | — | US | disclosed |
| US-9394279-B2 | Anti-viral compounds | ABBVIE INC. (US) | 2016-07-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160297804-A1 | 9,9,10,10-TETRAFLUORO-9,10-DIHYDROPHENANTHRENE HEPATITIS C VIRUS INHIBITOR AND APPLICATION THEREOF | SLC10A1, CYP2C9, UGT1A9 | SCN10A 208/4885CHRNB2 4865/4885CHRNA7 4624/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.